Q1 2025 Holdings
Filed 2025-05-15 | 32 holdings | $2.8B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Spdr S&P 500 ETF TR(SPY)Put | TR UNIT | 78462F103 | $839.1M | 1,500,000 | 29.8% |
| Zimmer Biomet Holdings Inc(ZBH) | COM | 98956P102 | $254.7M | 2,250,000 | 9.0% |
| Baxter Intl Inc(BAX) | COM | 071813109 | $196.8M | 5,750,000 | 7.0% |
| Humana Inc(HUM) | COM | 444859102 | $191.8M | 725,000 | 6.8% |
| Pfizer Inc(PFE)Call | COM | 717081103 | $172.3M | 6,800,000 | 6.1% |
| Spdr SER TR(XBI)Put | S&P BIOTECH | 78464A870 | $162.2M | 2,000,000 | 5.8% |
| CVS Health Corp(CVS) | COM | 126650100 | $152.4M | 2,250,000 | 5.4% |
| Globus MED Inc(GMED) | CL A | 379577208 | $91.5M | 1,250,000 | 3.3% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $76.4M | 1,500,000 | 2.7% |
| The Cigna Group(CI) | COM | 125523100 | $65.8M | 200,000 | 2.3% |
| Viatris Inc(VTRS) | COM | 92556V106 | $65.3M | 7,500,000 | 2.3% |
| Pfizer Inc(PFE) | COM | 717081103 | $63.4M | 2,500,000 | 2.3% |
| Qiagen NV(QGEN) | COM SHS | N72482206 | $56.2M | 1,400,000 | 2.0% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $54.6M | 350,000 | 1.9% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $51.1M | 800,000 | 1.8% |
| Brookdale SR Living Inc(BKD) | COM | 112463104 | $39.1M | 6,250,000 | 1.4% |
| GSK PLC(GSK)Call | SPONSORED ADR | 37733W204 | $38.7M | 1,000,000 | 1.4% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $35.3M | 500,000 | 1.3% |
| Concentra Group Holdings PAR(CON) | COMMON STOCK | 20603L102 | $34.7M | 1,600,000 | 1.2% |
| Evolent Health Inc(EVH) | CL A | 30050B101 | $28.4M | 3,000,000 | 1.0% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $21.9M | 725,000 | 0.8% |
| Myriad Genetics Inc(MYGN) | COM | 62855J104 | $20.8M | 2,350,000 | 0.7% |
| Zimvie Inc(ZIMV) | COM | 98888T107 | $20.4M | 1,885,000 | 0.7% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $17.2M | 441,000 | 0.6% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $17.0M | 1,250,000 | 0.6% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $13.9M | 750,000 | 0.5% |
| Theravance Biopharma Inc(TBPH) | COM | G8807B106 | $8.9M | 1,000,000 | 0.3% |
| 10X Genomics Inc(TXG) | CL A COM | 88025U109 | $8.7M | 1,000,000 | 0.3% |
| Inogen Inc(INGN) | COM | 45780L104 | $7.0M | 975,000 | 0.2% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $5.2M | 300,000 | 0.2% |
| Orasure Technologies Inc(OSUR) | COM | 68554V108 | $3.0M | 900,000 | 0.1% |
| Genmab A/S(GMAB) | SPONSORED ADS | 372303206 | $979.0K | 50,000 | 0.0% |